REDUCE LAP-HF TRIAL II

StatusUnknown
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Feb 2023); last known: Active, Not Recruiting
  2. Study sites: 92 to 91v17
  3. Study sites: 107 to 92
    • Eligibility criteria revised
    v16
  4. Primary completion date changed from estimate of Aug 2021 to Jul 29, 2021
    • Study completion date: Aug 2027 to Sep 2026
    • Secondary endpoints: details revised at 1 of 4 entries
    • Study description shortened, about 41 words
    v15
  5. Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 118 to 107
    v14
Show 12 earlier versionsHide 12 earlier versions
  1. Primary completion date: Dec 2020 to Aug 2021v13 Show 5 more changesShow less
    • Primary endpoint revised
    • Study completion date: Jul 2025 to Aug 2027
    • Eligibility criteria revised
    • Secondary endpoints: 2 to 4
    • Study sites revised (118)
  2. Site details revised at 1 of 118 sitesv12
  3. Study sites: 107 to 118v11
  4. Study completion date: Jul 2024 to Jul 2025
    • Eligibility criteria shortened, about 26 words
    v10
  5. Study sites: 65 to 107v9
  6. Study sites: 47 to 65v8
  7. Enrollment target: 380 to 608v7 Show 4 more changesShow less
    • Primary endpoint revised
    • Study sites: 45 to 47
    • Secondary endpoints revised (2)
    • Eligibility criteria expanded, about 2 words
  8. Study sites: 18 to 45v6
  9. Site details revised at 8 of 18 sitesv5
  10. Lead sponsor: [Redacted] to Corvia Medicalv4 Show 5 more changesShow less
    • Trial status: Withheld to Recruiting
    • Primary completion date: Dec 2020
    • Study completion date: Jul 2024
    • Start date: Jun 1, 2017
    • Study title shortened, about 9 words
  11. 2 versions Re-verified since Mar 22, 2017, no change to tracked fieldsv2-v3
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Corvia Medical
5 trials monitored
See all monitored trials
Heart Disease
8,814 trials monitored
See 428 trials at risk
Heart Failure
2,000 trials monitored
See 115 trials at risk
Multicenter, Prospective, Randomized Controlled, Blinded Trial, with a Non-implant Control group; 1:1 randomization.
Trial Details
NCT Number NCT03088033
Lead Sponsor Corvia Medical
Conditions
(from sponsor)		 Heart Failure
Related terms Heart Failure
Enrollment 608 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov